Diaprost AB
Share:
Subscribe:

Johan Drott CEO Diaprost AB

Tue, Dec 13, 2016 07:00 CET

Medium resolution

Original resolution

Subscribe

Related Releases

Study demonstrates the feasibility of targeting human kallikrein-related peptidase 2 (hK2) for detection and monitoring of prostate cancer Tue, Dec 13, 2016 07:00 CET